Will whole-genome sequencing become the norm?

The first thing Debbie Jorde noticed about her newborn daughter was that her arms were bent at unnatural angles. She had other problems, too: a cleft palate, eight fingers, eight toes and no lower eyelids. She would eventually be diagnosed with Miller syndrome, a disease so rare that doctors have long assumed that each case arises through spontaneous mutation, rather than being passed down through families. Doctors told Jorde that her chances of having a second child with the syndrome were less than one in a million.

They were wrong. Jorde’s son, born three years after his sister, had the same features. Lynn Jorde, Debbie’s current husband and a geneticist at the University of Utah in Salt Lake City, still cringes when Debbie recounts what the doctors had told her. “The right answer for that situation is that there have been so few cases that we really can’t predict the risk,” he says.

Thanks to next-generation genome sequencing, Debbie and her children now know the family’s genetic risks. Lynn and his collaborators had been talking about sequencing the genomes of an entire ‘nuclear’ family affected by a genetic disease, both to identify the mutation responsible and to investigate how genes are inherited in unprecedented detail. Debbie, her former husband and her now-adult children, Heather and Logan Madsen, were happy to be take part, and in 2009 became the first family in the world to have their genomes fully sequenced.

Read the full, original story: Human genetics: Genomes on prescription

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Wave Crest Over Red Cross
Viewpoint: Here are the election-inspired Trump administration healthcare policy reversals expected in the coming months
Supplement Rain Wellness Illustration
Viewpoint: Bedeviled by “toxic inflammation”? How wellness grifters turn this scientific gray zone into a supplement jackpot
Aerial Sprayer Over Gradient Fields
Farming, food, and chemicals: Post-midterms, the MAHA alliance between Democrats and MAGA Republicans is bruised but not cowed. What comes next?
Teal Hexagon Technology Icons
4 key ways the Blue Wave will upend science policy
Confident Doctor in Clinical Setting
More than 80% of ‘pro-science’ candidates were swept into office. Will they have a policy impact?
Stacked Protest Signs on Concrete Ledge
Voters hate AI data centers, yet they are crucial to establishing a critical technology. So what’s next?
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
Protect-Womens-Sports-at-the-Capitol
Blue, purple and red states passed or reaffirmed bans on trans females competing in women’s sports
Democratic Donkey Plowing at Sunset
Viewpoint: Democratic tsunami: As the red tide recedes, here are the most likely shifts in food and agricultural policy
Screenshot-2026-11-05-at-1.20.54-PM
$7.35 billion PFAS settlement: 3M to pay people who blame health problems on ‘forever chemicals’ phased out of firefighting foam for more than 20 years
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.